Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000804
Status:
WITHDRAWN
Last Update Posted:
2016-12-14
First Post:
1999-11-02
Brief Title:
A Randomized Trial of L-735524 An Inhibitor of the HIV Protease Enzyme and Interleukin-2 in Persons Infected With HIV NOTE Only For Patients Who Previously Completed NIAID 93 CC-113
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
A Randomized Trial of L-735524 An Inhibitor of the HIV Protease Enzyme and Interleukin-2 in Persons Infected With HIV NOTE Only For Patients Who Previously Completed NIAID 93 CC-113
Status:
WITHDRAWN
Status Verified Date:
2003-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to study L-735524 which is an inhibitor of the HIV protease enzyme It will be used with interleukin-2 in patients infected with HIV
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: